Physician

David A Schmerler, DO

According to 2025 Medicare claims, David Schmerler, DO (NPI: 1760707574) practices neurology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Hamilton, OH. This provider's primary affiliated billing organization is RIVERHILLS HEALTHCARE INC (NPI: 1205943651; TIN: 311412447) and primary practice location at 45212-2280. Schmerler is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Schmerler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 515 traditional Medicare patients, billed 46,251 HCPCS/CPT codes, and received $687,338 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 3,199 prescription claims across 610 beneficiaries totaling $706,623 in drug costs, led by Rytary (Carbidopa/Levodopa). Open Payments data shows 22 records totaling $6,857. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $38,356 and ending at $687,338. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $148,290 to $706,623. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	187	1,267	$38,356
2017	460	12,417	$383,035
2018	525	27,938	$779,976
2019	523	45,151	$1,074,348
2020	473	46,522	$1,281,877
2021	498	27,623	$458,398
2022	483	35,392	$607,050
2023	530	35,188	$507,081
2024	515	46,251	$687,338

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	117	707	$148,290
2016	208	886	$185,950
2017	329	2,067	$318,843
2018	376	2,321	$514,773
2019	428	2,735	$549,660
2020	419	3,084	$793,315
2021	437	2,466	$962,612
2022	445	2,116	$939,392
2023	448	2,223	$648,194
2024	610	3,199	$706,623

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	108	108	$144
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	143	182	$128
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	234	291	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	136	147	$67
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	219	239	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rytary	Carbidopa/Levodopa	180	9,034	$243,249
Gocovri	Amantadine Hcl	28	1,140	$114,062
Nuplazid	Pimavanserin Tartrate	14	480	$75,531
Ubrelvy	Ubrogepant	23	328	$32,415
Carbidopa-Levodopa	Carbidopa/Levodopa	764	46,225	$31,848

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$6,857	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David A. Schmerler, DO?

Tedicare shows public-source Medicare data for David A. Schmerler, DO (NPI 1760707574), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David A. Schmerler, DO have ACO affiliation data?

David A. Schmerler, DO is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to David A. Schmerler, DO?

David A. Schmerler, DO is linked to RIVERHILLS HEALTHCARE INC (billing NPI 1205943651) in the available physician profile data.

Does David A. Schmerler, DO have Open Payments data?

David A. Schmerler, DO has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.